NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
02/04/2025
Back to search
Official data from USPTO
ULTRA FOCAL THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ULTRA FOCAL THERAPY
ST13
US500000087372860Class
44
Filing
87372860
Registration
5376877
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
02/04/2025
Trademark type
Word
Nice classes
44
Filing date
03/15/2017
Registration date
01/09/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2025
Last transaction
02/04/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/01/2016
First use in commerce
05/01/2016
Drawing code
4
Owner type
03
Owner location
New York, NY
Examiner
MAI, TINA
Current location
Historical data usage
Holders and representatives
Holders
P. U. (pessoa física)
Representatives
Thomas M. Dunlap Dunlap Bennett & Ludwig PLLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical diagnosis and treatment of prostate cancer
Publications
History of USPTO decisions and trademark events.
39 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/14/2025
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/14/2025
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
01/14/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
01/10/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
01/10/2025
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
10/11/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/11/2024
E815
TEAS SECTION 8 & 15 RECEIVED
04/13/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/21/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/21/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/21/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/08/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/07/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/20/2017
IUAF
USE AMENDMENT FILED
11/01/2017
EISU
TEAS STATEMENT OF USE RECEIVED
11/01/2017
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
10/29/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/29/2017
INCS
ITU OFFICE ACTION ISSUED FOR STATEMENT OF USE
10/27/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/26/2017
EISU
TEAS STATEMENT OF USE RECEIVED
10/15/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/10/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/15/2017
PUBO
PUBLISHED FOR OPPOSITION
08/15/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/26/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/15/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
06/15/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/15/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
06/15/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/15/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/15/2017
GNRT
NON-FINAL ACTION E-MAILED
06/15/2017
CNRT
NON-FINAL ACTION WRITTEN
06/15/2017
DOCK
ASSIGNED TO EXAMINER
06/08/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/21/2017
NWAP
NEW APPLICATION ENTERED
03/18/2017
Continuous trademark protection
Get notified about every new filing that threatens ULTRA FOCAL THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.